Earnings Intelligence

Insight-rich articles built from earnings calls.
Stay ahead with how businesses evolve.

High-Value Insights

Articles with exceptional investment signal

20
TVTX
Biotechnology

Travere Therapeutics (TVTX) Q1 2025: Filspari Sales Surge 182% YoY, Setting Up FSGS Launch

Travere demonstrates a long reinvestment runway, exceptional recent growth (182% YoY Filspari sales), improving unit economics, self-reinforcing business model, and deepening...

Read full analysis →
20
APP
Software - Application

Applovin (APP) Q3 2025: 68% Revenue Surge Driven by Model Upgrades and Self-Service Ramp

Applovin demonstrates a long reinvestment runway with high returns, a disruptive business model, and self-reinforcing economics. The business is showing massive growth (68%...

Read full analysis →
20
TEM
Health Information Services

Tempest (TEM) Q1 2025: Data Contracts Top $1B as Genomics Revenue Jumps 89%

Tempest exhibits all the hallmarks of a high-signal, inflecting business: a long reinvestment runway, disruptive data/AI-driven business model, accelerating growth (both...

Read full analysis →
20
MU
Semiconductors

Micron (MU) Q1 2026: HBM Revenue Fully Booked for 2026 as $20B CapEx Signals AI-Driven Supply Squeeze

Micron demonstrates a rare and powerful supply-constrained inflection, with full HBM bookings, long-term contracts, and margin/cash flow acceleration. The business model is...

Read full analysis →
20
UXIN
Auto & Truck Dealerships

UXIN Q4 2024: Retail Volume Jumps 178% as Superstore Model Scales Profitability

UXIN demonstrates a long reinvestment runway, a disruptive business model, and clear evidence of accelerating growth and margin expansion. Unit economics are improving, the...

Read full analysis →
20
ALNY
Biotechnology

Alnylam (ALNY) Q2 2025: TTR Franchise Surges 77% on Ambutra Launch, Guidance Raised $575M

Alnylam demonstrates a long reinvestment runway (pipeline, global launches), a disruptive RNAi platform, and a step-change in growth (TTR franchise +77%, guidance up $575M)....

Read full analysis →
20
MIRM
Biotechnology

MIRUM (MIRM) Q1 2025: Livmarli Tablet Approval and 61% Revenue Growth Signal Rare Disease Leadership

MIRUM demonstrates a long reinvestment runway, significant recent growth, improving unit economics, and a self-reinforcing rare disease model. Customer value is increasing,...

Read full analysis →
20
LLY
Drug Manufacturers - General

Eli Lilly (LLY) Q1 2025: 45% Revenue Surge as Obesity and Diabetes Pipeline Redefines Growth Trajectory

Eli Lilly demonstrates a long and clear reinvestment runway, with blockbuster growth, margin expansion, and a disruptive business model centered on metabolic disease. The 45%...

Read full analysis →
View All Insights
EARNINGS INTELLIGENCE

Make Better Investment Decisions

Decode earnings calls with AI-powered analysis.
Spot trends before the market catches on.

About EarningsIQ

EarningsIQ is a strategic reading layer on top of earnings season. We surface company performance, executive priorities, and macro signals, so investors can stay in sync without parsing transcripts.

Join the Smartest Earnings Read in the Market

Subscribe to The Earnings Dispatch
for strategic insights delivered weekly to your inbox.

Free weekly brief. Unsubscribe anytime.

What EarningsIQ Delivers

Actionable Insights

Distilled analysis from earnings calls that cuts through the noise and highlights what truly matters for your investment decisions.

Market Trends

Early identification of emerging sector trends and themes before they become mainstream, giving you an edge in positioning your portfolio.

Time Efficiency

Hours of research condensed into concise, mobile-friendly weekly updates that respect your time while keeping you informed.

Earnings Calendar

Date Company Article
January 30 WT Read
January 30 SBFG Read
January 30 CHD Read
January 30 FHB Read
January 30 HITI Read
January 30 WT Read
January 30 FBIZ Read
January 30 ALV Read
January 30 CVCO Read
January 30 LYB Read

Why Earnings Intelligence Matters

In today's fast-moving markets, the signals that drive tomorrow's price movements are often hidden in today's earnings calls.

01

Quarterly earnings calls provide the earliest indicators of business momentum shifts, often weeks before they appear in technical charts.

02

Management commentary offers invaluable forward guidance that helps you anticipate market movements rather than react to them.

03

Our focused analysis helps you separate meaningful signals from market noise, enabling more confident investment decisions.

Stay Strategically Informed

Get The Dispatch , our weekly newsletter
that decodes earnings calls so you can invest with clarity.

Join 10,000+ investors receiving our weekly insights.